Speciality Medicines (SPML) has submitted its financial results for the half year and fiscal year ending March 31, 2026 on the BSE platform.
Speciality Medicines has submitted its H2 and FY2026 financial results to BSE for the period ending March 31, 2026.
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."
No credit card required. Connect WhatsApp or Telegram in minutes.